These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 32553383)

  • 41. Protein kinase Mζ in medial prefrontal cortex mediates depressive-like behavior and antidepressant response.
    Yan W; Liu JF; Han Y; Zhang W; Luo YX; Xue YX; Zhu WL; Yang C; Chen WH; Guo HL; Ma YN; Yuan K; Wang JS; Shi J; Lu L
    Mol Psychiatry; 2018 Sep; 23(9):1878-1891. PubMed ID: 29180675
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Ketamine-induced antidepressant effects are associated with AMPA receptors-mediated upregulation of mTOR and BDNF in rat hippocampus and prefrontal cortex.
    Zhou W; Wang N; Yang C; Li XM; Zhou ZQ; Yang JJ
    Eur Psychiatry; 2014 Sep; 29(7):419-23. PubMed ID: 24321772
    [TBL] [Abstract][Full Text] [Related]  

  • 43. New Hippocampal Neurons Mature Rapidly in Response to Ketamine But Are Not Required for Its Acute Antidepressant Effects on Neophagia in Rats.
    Soumier A; Carter RM; Schoenfeld TJ; Cameron HA
    eNeuro; 2016; 3(2):. PubMed ID: 27066531
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antidepressant but Not Prophylactic Ketamine Administration Alters Calretinin and Calbindin Expression in the Ventral Hippocampus.
    LaGamma CT; Tang WW; Morgan AA; McGowan JC; Brachman RA; Denny CA
    Front Mol Neurosci; 2018; 11():404. PubMed ID: 30459554
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inflammation, stress and depression: An exploration of ketamine's therapeutic profile.
    Johnston JN; Greenwald MS; Henter ID; Kraus C; Mkrtchian A; Clark NG; Park LT; Gold P; Zarate CA; Kadriu B
    Drug Discov Today; 2023 Apr; 28(4):103518. PubMed ID: 36758932
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Up-regulation of insulin-like growth factor 2 by ketamine requires glycogen synthase kinase-3 inhibition.
    Grieco SF; Cheng Y; Eldar-Finkelman H; Jope RS; Beurel E
    Prog Neuropsychopharmacol Biol Psychiatry; 2017 Jan; 72():49-54. PubMed ID: 27542584
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Ketamine, but not MK-801, produces antidepressant-like effects in rats responding on a differential-reinforcement-of-low-rate operant schedule.
    Hillhouse TM; Porter JH
    Behav Pharmacol; 2014 Feb; 25(1):80-91. PubMed ID: 24370559
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Acute administration of ketamine induces antidepressant-like effects in the forced swimming test and increases BDNF levels in the rat hippocampus.
    Garcia LS; Comim CM; Valvassori SS; Réus GZ; Barbosa LM; Andreazza AC; Stertz L; Fries GR; Gavioli EC; Kapczinski F; Quevedo J
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jan; 32(1):140-4. PubMed ID: 17884272
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ketamine interactions with gut-microbiota in rats: relevance to its antidepressant and anti-inflammatory properties.
    Getachew B; Aubee JI; Schottenfeld RS; Csoka AB; Thompson KM; Tizabi Y
    BMC Microbiol; 2018 Dec; 18(1):222. PubMed ID: 30579332
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Ketamine and imipramine in the nucleus accumbens regulate histone deacetylation induced by maternal deprivation and are critical for associated behaviors.
    Réus GZ; Abelaira HM; dos Santos MA; Carlessi AS; Tomaz DB; Neotti MV; Liranço JL; Gubert C; Barth M; Kapczinski F; Quevedo J
    Behav Brain Res; 2013 Nov; 256():451-6. PubMed ID: 24004850
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antidepressant drugs for beta amyloid-induced depression: A new standpoint?
    Schiavone S; Tucci P; Mhillaj E; Bove M; Trabace L; Morgese MG
    Prog Neuropsychopharmacol Biol Psychiatry; 2017 Aug; 78():114-122. PubMed ID: 28499898
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mechanistic Target of Rapamycin-Independent Antidepressant Effects of (R)-Ketamine in a Social Defeat Stress Model.
    Yang C; Ren Q; Qu Y; Zhang JC; Ma M; Dong C; Hashimoto K
    Biol Psychiatry; 2018 Jan; 83(1):18-28. PubMed ID: 28651788
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Ketamine's antidepressant action: beyond NMDA receptor inhibition.
    Hashimoto K
    Expert Opin Ther Targets; 2016 Nov; 20(11):1389-1392. PubMed ID: 27646666
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Molecular profile of dissociative drug ketamine in relation to its rapid antidepressant action.
    Ficek J; Zygmunt M; Piechota M; Hoinkis D; Rodriguez Parkitna J; Przewlocki R; Korostynski M
    BMC Genomics; 2016 May; 17():362. PubMed ID: 27188165
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ketamine may exert antidepressant effects via suppressing NLRP3 inflammasome to upregulate AMPA receptors.
    Li JM; Liu LL; Su WJ; Wang B; Zhang T; Zhang Y; Jiang CL
    Neuropharmacology; 2019 Mar; 146():149-153. PubMed ID: 30496753
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of ketamine and N-methyl-D-aspartate on fluoxetine-induced antidepressant-related behavior using the forced swimming test.
    Owolabi RA; Akanmu MA; Adeyemi OI
    Neurosci Lett; 2014 Apr; 566():172-6. PubMed ID: 24530380
    [TBL] [Abstract][Full Text] [Related]  

  • 57. GABA interneurons are the cellular trigger for ketamine's rapid antidepressant actions.
    Gerhard DM; Pothula S; Liu RJ; Wu M; Li XY; Girgenti MJ; Taylor SR; Duman CH; Delpire E; Picciotto M; Wohleb ES; Duman RS
    J Clin Invest; 2020 Mar; 130(3):1336-1349. PubMed ID: 31743111
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Rapid-acting antidepressant ketamine, its metabolites and other candidates: A historical overview and future perspective.
    Hashimoto K
    Psychiatry Clin Neurosci; 2019 Oct; 73(10):613-627. PubMed ID: 31215725
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Impact of early-life stress, on group III mGlu receptor levels in the rat hippocampus: effects of ketamine, electroconvulsive shock therapy and fluoxetine treatment.
    O' Connor RM; Pusceddu MM; Dinan TG; Cryan JF
    Neuropharmacology; 2013 Mar; 66():236-41. PubMed ID: 22609536
    [TBL] [Abstract][Full Text] [Related]  

  • 60. N,N-dimethylglycine differentially modulates psychotomimetic and antidepressant-like effects of ketamine in mice.
    Lin JC; Chan MH; Lee MY; Chen YC; Chen HH
    Prog Neuropsychopharmacol Biol Psychiatry; 2016 Nov; 71():7-13. PubMed ID: 27296677
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.